HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Pulmonary Heart Diseases
Pulmonary Heart Diseases
Chronic lung conditions such as chronic obstructive pulmonary disease (COPD) and pulmonary hypertension can lead to a serious condition known as pulmonary heart diseases. When the blood vessels in the lungs become damaged or narrowed, the right side of the heart faces increased pressure, leading to strain and enlargement of the heart’s right ventricle. Over time, this can result in right heart failure. Pulmonary heart diseases often go unnoticed in the early stages, but with appropriate treatment, such as oxygen therapy, medications to reduce lung pressures, and lifestyle modifications, patients can manage their condition effectively. Addressing the root cause—often the underlying lung disease—remains crucial in improving outcomes.
Committee Members
Yong Xiao Wang
Albany Medical College, United States
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Narendra Kumar
HeartbeatsZ Academy, United Kingdom Heart Congress 2025 Speakers
Federico Benetti
Benetti Foundation, Argentina
Johannes Bonatti
University of Pittsburgh, United States
Eric J Lehr
Cherry Hill Campus, United States
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian FederationSubmit your abstract Today
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India